Breast Tumor Clinical Trial
Official title:
Diagnostic Performance of 68Gallium-labeled NOTA-RM26 PET/CT in Breast Tumor Patients
This is an open-label positron emission tomography/computed tomography(PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-RM26 in breast tumor patients. 1.85 MBq per kilogram body weight of 68Ga-NOTA-RM26A will be injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT images.
The gastrin-releasing peptide receptor (GRPR), also known as bombesin receptor subtype II (BB2), is a member of the G protein-coupled receptor family of bombesin receptors. GRPR is over-expressed in various types of human tumors including breast cancer. RM26, a GRPR antagonist with high affinity, was discovered by peptide backbone modification of bombesin analogues.To target gastrin-releasing peptide receptor in neoplastic cells of human breast cancer, peptide NOTA-RM26 was synthesized with a PEG3 linker between NOTA and RM26, and then labeled with 68Ga. An open-label whole-body PET/ CT study was designed to assess its clinical diagnostic value in patients with breast tumor. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05544123 -
The Treatment Situation of Chinese County Population With Breast Cancer
|
||
| Completed |
NCT01881230 -
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT05191004 -
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT01247480 -
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer
|
N/A | |
| Recruiting |
NCT04626986 -
Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor
|
N/A | |
| Completed |
NCT04805775 -
Desflurane and Postoperative Sleep Quality in Patients Undergoing Elective Breast Surgery
|
N/A | |
| Completed |
NCT03684408 -
Radiofrequency Chip for Localization of Non-Palpable Breast Lesions
|
N/A | |
| Recruiting |
NCT04692818 -
3D Ultrasound Breast Imaging
|
N/A | |
| Not yet recruiting |
NCT04825444 -
Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging System
|
||
| Recruiting |
NCT05252390 -
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT02470819 -
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
|
N/A | |
| Completed |
NCT00859261 -
Two Dimensional (2D) Silicon Transducer-Compression Plates for Breast Ultrasound
|
N/A | |
| Active, not recruiting |
NCT05169437 -
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
|
Phase 2 | |
| Recruiting |
NCT03870620 -
Metastatic Breast Cancer in Austria
|
||
| Completed |
NCT05185752 -
Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery
|
N/A | |
| Recruiting |
NCT04852926 -
Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.
|
||
| Recruiting |
NCT06172270 -
Sub-regional Tumor Segmentation Based on CEUS Perfusion Characteristics: Enhancing Breast Tumor Diagnosis
|
||
| Recruiting |
NCT04948983 -
The Effect of a Patient Decision Aids for Breast Cancer Screening
|
N/A | |
| Not yet recruiting |
NCT06251544 -
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
|
Phase 1 | |
| Terminated |
NCT02364960 -
Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)
|